Madison Investment Advisors LLC Buys New Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

Madison Investment Advisors LLC bought a new stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 6,946 shares of the company’s stock, valued at approximately $2,308,000.

Several other hedge funds have also recently added to or reduced their stakes in MEDP. GSA Capital Partners LLP bought a new stake in shares of Medpace in the 3rd quarter worth approximately $276,000. KBC Group NV lifted its position in shares of Medpace by 5.5% in the 3rd quarter. KBC Group NV now owns 1,213 shares of the company’s stock worth $405,000 after acquiring an additional 63 shares during the period. Zions Bancorporation N.A. lifted its position in shares of Medpace by 18.4% in the 3rd quarter. Zions Bancorporation N.A. now owns 7,118 shares of the company’s stock worth $2,376,000 after acquiring an additional 1,105 shares during the period. Sheaff Brock Investment Advisors LLC lifted its position in shares of Medpace by 0.8% in the 3rd quarter. Sheaff Brock Investment Advisors LLC now owns 5,476 shares of the company’s stock worth $1,828,000 after acquiring an additional 41 shares during the period. Finally, Natixis Advisors LLC bought a new stake in shares of Medpace in the 3rd quarter worth approximately $3,754,000. Institutional investors own 77.98% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Robert W. Baird raised their target price on Medpace from $354.00 to $362.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $381.44.

Medpace Price Performance

MEDP stock opened at $324.95 on Friday. The business has a fifty day moving average price of $340.28 and a 200 day moving average price of $341.42. Medpace Holdings, Inc. has a fifty-two week low of $302.01 and a fifty-two week high of $459.77. The stock has a market capitalization of $9.90 billion, a price-to-earnings ratio of 25.73, a P/E/G ratio of 3.81 and a beta of 1.47.

Medpace (NASDAQ:MEDP) last released its quarterly earnings results on Monday, February 10th. The company reported $3.67 earnings per share for the quarter, beating analysts’ consensus estimates of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. On average, equities analysts expect that Medpace Holdings, Inc. will post 12.29 earnings per share for the current fiscal year.

Medpace Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.